Louvain-la-Neuve, Belgium, 1 April 2020 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, today announces that a Virginia patient has completed the first proton therapy treatment cycle at the Inova Mather Proton Therapy Center, in Fairfax, Virginia, USA.
The Proteus® platform installed in Fairfax is an IBA Proteus®PLUS* solution with two gantry rooms, each equipped with Pencil Beam Scanning capability and integrated Cone Beam CT.
With 37 IBA-equipped proton therapy centers in operation – 25 Proteus®PLUS and 12 Proteus®ONE* – IBA has the largest users' community in proton therapy confirming IBA's leadership in the market. In addition, IBA is also leading innovation in proton therapy with future technologies such as proton ARC Therapy** and proton FLASH** irradiation on its Proteus® platform.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Olivier Legrain, Chief Executive Officer of IBA SA, commented: "We are pleased that Inova has made proton therapy accessible to more patients and completed its first proton therapy patient treatment. Congratulations to them for this milestone, we are looking forward to continuing and to expanding our collaboration with Inova. Having the Inova proton therapy center located near our North American Headquarters will facilitate our collaboration to further advance the use of proton therapy for cancer patients."
John Deeken, MD, President of the Inova Schar Cancer Institute, commented: "We are proud that with the addition of proton therapy, Inova Schar Cancer Institute offers yet another cutting-edge treatment to patients in Northern Virginia. Proton therapy is another aspect of the exceptional cancer care that we offer in one location, backed by our multidisciplinary approach of cancer specialists."
Dr. Gopal Bajaj, Chairman and Medical Director of Radiation Oncology at Inova Schar Cancer Institute, added: "The addition of proton therapy to our cancer center exemplifies Inova's commitment to providing the most comprehensive care to the patients we serve. This forward-looking approach to cancer care treatment is embodied throughout all aspects of Inova Schar Cancer Institute. We greatly value our clinical and technical collaboration with the team at IBA and are delighted to jointly celebrate this milestone on behalf of the residents of Northern Virginia."
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,400 people worldwide, IBA has installed systems across the world.